These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 17443226
1. Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome. Klusmann JH, Reinhardt D, Hasle H, Kaspers GJ, Creutzig U, Hahlen K, van den Heuvel-Eibrink MM, Zwaan CM. Leukemia; 2007 Jul; 21(7):1584-7. PubMed ID: 17443226 [No Abstract] [Full Text] [Related]
2. Megakaryoblastic leukemia and Down's syndrome: a review. Zipursky A, Peeters M, Poon A. Pediatr Hematol Oncol; 1987 Jul; 4(3):211-30. PubMed ID: 2978961 [Abstract] [Full Text] [Related]
9. Chromosome copy number and leukemia-lessons from Down's syndrome. Izraeli S. Hematology; 2005 Feb; 10 Suppl 1():164-6. PubMed ID: 16188662 [No Abstract] [Full Text] [Related]
10. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings. Rodrigues EF, da Costa ES, Land MG, Diamond HR, Ornellas MH, Abdelhay E, Fernandez Tde S. Cancer Genet Cytogenet; 2009 Jan 01; 188(1):54-6. PubMed ID: 19061782 [No Abstract] [Full Text] [Related]
11. Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome. Doyle JJ, Thorner P, Poon A, Tanswell K, Kamel-Reid S, Zipursky A. Leuk Lymphoma; 1995 Apr 01; 17(3-4):345-50. PubMed ID: 8580807 [Abstract] [Full Text] [Related]
12. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD. Nat Genet; 2002 Sep 01; 32(1):148-52. PubMed ID: 12172547 [Abstract] [Full Text] [Related]
13. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome. Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C. Leuk Res; 2005 Nov 01; 29(11):1353-6. PubMed ID: 15916804 [Abstract] [Full Text] [Related]
14. Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia. Mansini AP, Rubio PL, Rossi JG, Gallego MS, Medina A, Zubizarreta PA, Felice MS, Alonso CN. Arch Argent Pediatr; 2013 Dec 01; 111(6):532-6. PubMed ID: 24196768 [Abstract] [Full Text] [Related]
15. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder. Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E. J Pediatr Hematol Oncol; 2006 Oct 01; 28(10):696-8. PubMed ID: 17023834 [Abstract] [Full Text] [Related]
16. High frequency of copy number alterations in myeloid leukaemia of Down syndrome. Blink M, van den Heuvel-Eibrink MM, Aalbers AM, Balgobind BV, Hollink IH, Meijerink JP, van der Velden VH, Beverloo BH, de Haas V, Hasle H, Reinhardt D, Klusmann JH, Pieters R, Calado RT, Zwaan CM. Br J Haematol; 2012 Sep 01; 158(6):800-3. PubMed ID: 22775985 [No Abstract] [Full Text] [Related]
18. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Kiyoi H, Yamaji S, Kojima S, Naoe T. Leukemia; 2007 Mar 01; 21(3):574-6. PubMed ID: 17252020 [No Abstract] [Full Text] [Related]